Home › Kanser sa Thyroid › California
Pag-aaral pangklinika para sa Kanser sa Thyroid sa California
14 pag-aaral para sa Kanser sa Thyroid ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
DESTINY-PANTUMOUR04
- Research Site, San Diego
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05786924Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- at 20 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- The Unviersity of California, San Francisco (UCSF), San Francisco
Nagre-recruitPhase 2
Edad 2 hanggang 25 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- KP Southern California - Department of Research & Evaluation, Pasadena
Nagre-recruit
Edad 21 hanggang 45 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT07406087Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- University of California, San Francisco, San Francisco
Nagre-recruitPhase 2
Edad 13 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06961084A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116Active Surveillance of Papillary Thyroid Microcarcinoma
- Cedars-Sinai Medical Center, Los Angeles
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT02609685Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04119024Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT04742608Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- City of Hope Medical Center, Duarte
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT05229341cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- University of California, San Francisco, San Francisco
Nagre-recruitPhase 2
Edad 2 hanggang 99 · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT05783323APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 27, 2025 · NCT03175224Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.